Literature DB >> 9824610

Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Q W Xu1, R B Scott, D T Tan, E A Shaffer.   

Abstract

BACKGROUND: The ground squirrel on a high cholesterol diet exhibits prolonged intestinal transit, a pathogenetic factor in cholesterol gallstone formation. AIMS: To examine the effect of a high cholesterol diet on the characteristics of the migrating myoelectrical complex (MMC) and the potential benefit of erythromycin.
METHODS: Twenty four animals received either a trace (controls) or a 1% (high) cholesterol diet. After four weeks, five bipolar jejunal and terminal ileal electrodes were implanted. Seven days later, myoelectric activity was measured in conscious, fasted animals before and after treatment with erythromycin. Biliary lipid composition was assessed.
RESULTS: Compared with controls, animals fed the high cholesterol diet exhibited a prolonged MMC cycle period (70 (6) versus 83 (3) minutes; p<0.05), whereas MMC migration velocity and the proportions of the MMC represented by phases I, II, and III were unchanged. Oral erythromycin significantly shortened the MMC cycle period in animals on the control and high cholesterol diet by 59% and 54% respectively, and increased the proportion of the cycle period occupied by phase III of the MMC in both dietary groups. Gall bladder bile became saturated with cholesterol and crystals developed in nine of 12 animals on the high cholesterol diet; controls had none.
CONCLUSION: Animals fed a high cholesterol diet had a prolonged MMC cycle period. This, along with diminished gall bladder motility, impairs the enterohepatic cycling of bile salts and reduces their hepatic secretion, contributing to the formation of abnormal bile. Erythromycin initiated more frequent cycling of the MMC. Its therapeutic value in cholesterol gallstone formation warrants further evaluation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824610      PMCID: PMC1727362          DOI: 10.1136/gut.43.6.817

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  The potential site of impaired gallbladder contractility in an animal model of cholesterol gallstone disease.

Authors:  Q W Xu; E A Shaffer
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

2.  Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

3.  Excess membrane cholesterol alters calcium channels in arterial smooth muscle.

Authors:  R A Bialecki; T N Tulenko
Journal:  Am J Physiol       Date:  1989-08

4.  Altered contractile and ion channel function in rabbit portal vein with dietary atherosclerosis.

Authors:  R H Cox; T N Tulenko
Journal:  Am J Physiol       Date:  1995-06

5.  Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.

Authors:  Q W Xu; E A Shaffer
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

6.  Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.

Authors:  D M Heuman; R Bajaj
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

7.  Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction.

Authors:  J H Kim; M L Klyachkin; E Svendsen; M G Davies; P O Hagen; C C Carson
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

8.  Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis.

Authors:  R P Jazrawi; P Pazzi; M L Petroni; N Prandini; C Paul; J A Adam; S Gullini; T C Northfield
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

9.  Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.

Authors:  J Shoda; B F He; N Tanaka; Y Matsuzaki; T Osuga; S Yamamori; H Miyazaki; J Sjövall
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

10.  Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones.

Authors:  F Kern
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  3 in total

1.  Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.

Authors:  A Colecchia; G Mazzella; L Sandri; F Azzaroli; M Magliuolo; P Simoni; M L Bacchi-Reggiani; E Roda; D Festi
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Authors:  Piero Portincasa; Antonio Moschetta; Massimo Berardino; Agostino Di-Ciaula; Michele Vacca; Giuseppe Baldassarre; Anna Pietrapertosa; Rosario Cammarota; Nunzia Tannoia; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

3.  Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet.

Authors:  Ronald Mathison; Eldon Shaffer; Hans-Juergen Pfannkuche; David Earnest
Journal:  Lipids Health Dis       Date:  2006-06-22       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.